Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 98 Biopsy 69 Magnetic Resonance Spectroscopy 63 pembrolizumab 46 Cyclophosphamide 43 fludarabine 38 Carboplatin 22 venetoclax 19 Nivolumab 18 Cetuximab 18 Bevacizumab 17 Radiotherapy 16 fludarabine phosphate 15 Cisplatin 15 X-Rays 14 Ipilimumab 13 Fluorouracil 13 Cytarabine 13 Temozolomide 12 Leucovorin 12 Irinotecan 12 atezolizumab 11 Radiation 11 Paclitaxel 11 Azacitidine 11 durvalumab 10 Oxaliplatin 10 Injections 10 Gemcitabine 10 Dexamethasone 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × zimberelimab × 30 days × Clear all

NCT04104672 2026-05-07

ARC-8

Arcus Biosciences, Inc.

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡